Onychomycosis: Diagnosis and management

Indian Journal of Dermatology, Venereology and Leprology

Volumn 77, Issue 6, 2011, Pages 659-672

  Singal, Archana ^a   Khanna, Deepshikha ^b  

^a UNIVERSITY OF DELHI   (India)

^b Chacha Nehru Bal Chikitsalaya   (India)

Author keywords

Candida; dermatophyte; itraconazole; nail lacquer; non dermatophytic molds; onychomycosis; terbinafine

Indexed keywords

5 FLUORO 1,3 DIHYDRO 2,1 BENZOXABOROL 1 OL; AMOROLFINE; CICLOPIROX; CISAPRIDE; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; PIMOZIDE; QUINIDINE; RAVUCONAZOLE; TERBINAFINE; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACREMONIUM; AGRANULOCYTOSIS; APPLICATION SITE BURNING; APPLICATION SITE ERYTHEMA; ARTICLE; ASPERGILLUS; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CELLULITIS; CLUBBING FINGERS; CONFOCAL MICROSCOPY; DEBRIDEMENT; DERMATOPHYTOSIS; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC PATIENT; DRUG DELIVERY SYSTEM; DRUG WITHDRAWAL; EMBEDDING; ENZYME DEFECT; EPIDERMOPHYTON FLOCCOSUM; FINGERNAIL ONYCHOMYCOSIS; FUNGUS CULTURE; FUNGUS ISOLATION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GOLD STANDARD; HEADACHE; HEART PALPITATION; HEPATITIS; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOHISTOCHEMISTRY; INSOMNIA; IONTOPHORESIS; LABORATORY DIAGNOSIS; LACTATION; LASER SURGERY; LICHEN PLANUS; LIVER DISEASE; META ANALYSIS (TOPIC); MIXED INFECTION; MOULD; ONYCHOLYSIS; ONYCHOMYCOSIS; PARONYCHIA; PERIODIC ACID SCHIFF STAIN; PHOTODYNAMIC THERAPY; PREGNANCY; PREVALENCE; PRURITUS; PSORIASIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REINFECTION; RELAPSE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCANNING ELECTRON MICROSCOPY; SCOPULARIOPSIS BREVICAULIS; SKIN DISCOLORATION; SKIN LUPUS ERYTHEMATOSUS; SWIMMING POOL; TASTE DISORDER; TISSUE SECTION; TOENAIL ONYCHOMYCOSIS; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; ULTRASOUND; URTICARIA;

ANTIFUNGAL AGENTS; DRUG THERAPY, COMBINATION; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; ONYCHOMYCOSIS; PARONYCHIA;

EID: 80155167720     PISSN: 03786323     EISSN: 09733922     Source Type: Journal    
DOI: 10.4103/0378-6323.86475     Document Type: Article

References (73)

1. Kaur R, Kashyap B, Bhalla P. Onychomycosis-epidemiology, diagnosis and management. Indian J Med Microbiol 2008;26:108-16.
2. Baran R, Hay R, Haneke E, Tosti A, editors. Onychomycosis: The current approach to diagnosis and therapy. London: Informa Healthcare; 2006.
3. Sehgal VN, Srivastava G, Dogra S, Chaudhary A, Adhikari T. Onychomycosis: An Asian perspective. Skinmed 2010;8:37-45.
4. Arrese JE, Piérard GE. Treatment failures and relapses in onychomycosis: A stubborn clinical problem. Dermatology 2003;207:255-60. (Pubitemid 37329194)
5. Tosti A, Piraccini BM, Lorenzi S. Onychomycosis caused by nondermatophytic molds: Clinical features and response to treatment of 59 cases. J Am Acad Dermatol 2000;42:217-24. (Pubitemid 30469618)
6. Jayayatilake JA, Tilakaratne WM, Panagoda GJ. Candida onychomycosis: A mini-review. Mycopathologia 2009;168: 165-73.
7. Baran R, Hay R, Perrin C. Superficial white onychomycosis revisited. J Eur Acad Dermatol Venereol 2004;18:569-71. (Pubitemid 39255747)
8. Haldane DJ, Robart E. A comparison of calcofluor white, potassium hydroxide, and culture for the laboratory diagnosis of superficial fungal infection. Diagn Microbiol Infect Dis 1990;13:337-9. (Pubitemid 20260752)
9. Weinberg JM, Koestenblatt EK, Tutrone WD, Tishler HR, Najarian L. Comparision of diagnostic methods in the evaluation of onychomycosis. J Am Acad Dermatol 2003;49:193-7. (Pubitemid 36951263)
10. Shemer A, Trau H, Davidovici B, Grunwald MH, Amichai B. Collection of fungi samples from nails: Comparative study of curettage and drilling techniques. J Eur Acad Dermatol Venereol 2008;22:182-5.
11. Gianni C, Morelli V, Cerri A, Greco C, Rossini P, Guiducci A, et al. Usefulness of histological examination for the diagnosis of onychomycosis. Dermatology 2001;202:283-8. (Pubitemid 32664521)
12. Bontems O, Hauser PM, Monod M. Evaluation of a polymerase chain reaction-restriction fragment length polymorphism assay for dermatophyte and nondermatophyte identification in onychomycosis. Br J Dermatol 2009;161:791-6.
13. Gupta AK, Zaman M, Singh J. Diagnosis of Trichophyton rubrum from onychomycotic nail samples using polymerase chain reaction and calcofluor white microscopy. J Am Podiatr Med Assoc 2008;98:224-8.
14. Scherer WP, Scherer MD. Scanning electron microscope imaging of onychomycosis. J Am Podiatr Med Assoc 2004;94:356-62. (Pubitemid 39077677)
15. Roberts DT, Taylor WD, Boyle J. British Association of Dermatologists. Guidelines for treatment of onychomycosis. Br J Dermatol 2003;148:402-10. (Pubitemid 36461317)
16. Lecha M, Effendy I, Feuilhade de Chauvin M, Di Chiacchio N, Baran R; Taskforce on Onychomycosis Education. Treatment options-development of consensus guidelines. J Eur Acad Dermatol Venereol 2005;19 Suppl 1:25-33. (Pubitemid 41726927)
17. Hay RJ. The future of onychomycosis therapy may involve a combination of approaches. Br J Dermatol 2001;145 Suppl 60:3-8.
18. Sidou F, Soto P. A randomized comparison of nail surface remanence of three nail lacquers, containing amorolfine 5%, ciclopirox 8% or tioconazole 28%, in healthy volunteers. Int J Tissue React 2004;26:17-24. (Pubitemid 39529819)
19. Gupta AK, Schouten JR, Lynch LE. Ciclopirox nail lacquer 8% for the treatment of onychomycosis: A Canadian perspective. Skin Therapy Lett 2005;10:1-3.
20. Rigopoulos D, Katsambas A, Antoniou C, Christofidou E, Balaskas E, Stratigos J. Discoloration of the nail plate due to the misuse of amorolfine 5 % nail lacquer. Acta Derm Venereol 1996;76:83-4. (Pubitemid 26088634)
21. Gupta AK, Ryder JE. The use of oral antifungal agents to treat onychomycosis. Dermatol Clin 2003;21:469-79. (Pubitemid 37022670)
22. Brown SJ. Efficacy of fluconazole for the treatment of onychomycosis. Ann Pharmacother 2009;43:1684-91.
23. Zisova LG. Fluconazole (Fungolon) in the treatment of onychomycosis. Folia Med (Plovdiv) 2004;46:47-50.
24. Scher RK, Breneman D, Rich P, Savin RC, Feingold DS, Konnikov N, et al. Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail. J Am Acad Dermatol 1998;38:S77-86. (Pubitemid 28275272)
25. Havu V, Brandt H, Heikkilä H, Hollmen A, Oksman R, Rantanen T, et al. A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis. Br J Dermatol 1997;136:230-4. (Pubitemid 27062726)
26. Srebrnik A, Levtov S, Ben-Ami R, Brenner S. Liver failure and transplantation after itraconazole treatment for toenail onychomycosis. J Eur Acad Dermatol Venereol 2005;19:205-7. (Pubitemid 40450426)
27. Cathcart S, Cantrell W, Elewski B. Onychomycosis and diabetes. J Eur Acad Dermatol Venereol 2009;23:1119-22.
28. Sigurgeirsson B, Billstein S, Rantanen T, Ruzicka T, di Fonzo E, Vermeer BJ, et al. L.I.ON. Study: Efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis. Br J Dermatol 1999;141 Suppl 56:5-14.
29. Gupta AK, Ryder JE, Johnson AM. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Br J Dermatol 2004;150:537-44. (Pubitemid 38446311)
30. Piraccini BM, Sisti A, Tosti A. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents. J Am Acad Dermatol 2010;62:411-4.
31. Cribier BJ, Paul C. Long-term efficacy of antifungals in toenail onychomycosis: A critical review. Br J Dermatol 2001;145: 446-52. (Pubitemid 32953702)
32. Gupta AK, Lynch LE, Kogan N, Cooper EA. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis. J Eur Acad Dermatol Venereol 2009;23:256-62.
33. Takahata Y, Hiruma M, Shiraki Y, Tokuhisa Y, Sugita T, Muto M. Treatment of dermatophyte onychomycosis with three pulses of terbinafine (500 mg day for a week). Mycoses 2009;52:72-6.
34. Nakano N, Hiruma M, Shiraki Y, Chen X, Porgpermdee S, Ikeda S. Combination of pulse therapy with terbinafine tablets and topical terbinafine cream for the treatment of dermatophyte onychomycosis: A pilot study. J Dermatol 2006;33:753-8. (Pubitemid 44630137)
35. Sikder AU, Mamun SA, Chowdhury AH, Khan RM, Hoque MM. Study of oral itraconazole and terbinafine pulse therapy in onychomycosis. Mymensingh Med J 2006;15:71-80.
36. Bonsmann G, Schiller M, Luger TA, Ständer S. Terbinafineinduced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 2001;44:925-31. (Pubitemid 32493441)
37. Baran R, Tosti A, Hartmane I, Altmeyer P, Hercogova J, Koudelkova V, et al. An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis. J Eur Acad Dermatol Venereol 2009;23: 773-81.
38. Baran R, Coquard F. Combination of fluconazole and urea in a nail lacquer for treating onychomycosis. J Dermatolog Treat 2005;16:52-5. (Pubitemid 40283326)
39. Ghannoum MA, Long L, Pfister WR. Determination of the efficacy of terbinafine hydrochloride nail solution in the topical treatment of dermatophytosis in a guinea pig model. Mycoses 2009;52:35-43.
40. Amichai B, Nitzan B, Mosckovitz R, Shemer A. Iontophoretic delivery of terbinafine in onychomycosis: A preliminary study. Br J Dermatol 2010;162:46-50.
41. Hui X, Baker SJ, Wester RC, Barbadillo S, Cashmore AK, Sanders V, et al. In vitro penetration of a novel oxaborole antifungal (AN2690) into the human nail plate. J Pharm Sci 2007;96:2622-31. (Pubitemid 47597813)
42. Murdan S. Enhancing the nail permeability of topically applied drugs. Expert Opin Drug Deliv 2008;5:1267-82.
43. Landsman AS, Robbins AH, Angelini PF, Wu CC, Cook J, Oster M, et al. Treatment of mild, moderate, and severe onychomycosis using 870-and 930-nm light exposure. J Am Podiatr Med Assoc 2010;100:166-77.
44. Hochman LG. Laser treatment of onychomycosis using a novel 0.65-millisecond pulsed Nd:YAG 1064-nm laser. J Cosmet Laser Ther 2011;13:2-5.
45. Manevitch Z, Lev D, Hochberg M, Palhan M, Lewis A, Enk CD. Direct antifungal effect of femtosecond laser on Trichophyton rubrum onychomycosis. Photochem Photobiol 2010;86:476-9.
46. Watanabe D, Kawamura C, Masuda Y, Akita Y, Tamada Y, Matsumoto Y. Successful treatment of toenail onychomycosis with photodynamic therapy. Arch Dermatol 2008;144:19-21. (Pubitemid 351159403)
47. Sotiriou E, Koussidou-Eremonti T, Chaidemenos G, Apalla Z, Ioannides D. Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by Trichophyton rubrum: Preliminary results of a single-centre open trial. Acta Derm Venereol 2010;90:216-7.
48. Dai T, Tegos GP, Rolz-Cruz G, Cumbie WE, Hamblin MR. Ultraviolet C inactivation of dermatophytes: Implications for treatment of onychomycosis. Br J Dermatol 2008;158:1239-46. (Pubitemid 351692876)
49. Bueno JG, Martinez C, Zapata B, Sanclemente G, Gallego M, Mesa AC. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis. Clin Exp Dermatol 2010;35:658-63.
50. Gupta AK, Leonardi C, Stoltz RR, Pierce PF, Conetta B; Ravuconazole onychomycosis group. A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis. J Eur Acad Dermatol Venereol 2005;19:437-43. (Pubitemid 40946096)
51. Lecha M. Amorolfine and itraconazole combination for severe toenail onychomycosis: Results of an open randomized trial in Spain. Br J Dermatol 2001;145 Suppl 60:21-6.
52. Baran R, Feuilhade M, Combernale P, Datry A, Goettmann S, Pietrini P, et al. A randomised trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region. Br J Dermatol 2000;142:1177-83. (Pubitemid 30418306)
53. Olafsson JH, Sigurgeirsson B, Baran R. Combination therapy for onychomycosis. Br J Dermatol 2003;149 Suppl 65:15-8. (Pubitemid 37410066)
54. Gupta AK, Lynde CW, Konnikov N. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. J Am Acad Dermatol 2001;44:485-91. (Pubitemid 32199969)
55. Piérard GE, Piérard-Franchimont C, Arrese JE. The boosted oral antifungal treatment for onychomycosis beyond the regular itraconazole pulse dosing regimen. Dermatology 2000;200:185-7. (Pubitemid 30199344)
56. Pierard GE, Pierard-Franchimont C, Arrese JE. The boosted antifungal topical treatment (BATT) for onychomycosis. Med Mycol 2000;38:391-2.
57. Malay DS, Yi S, Borowsky P, Downey MS, Mlodzienski AJ. Efficacy of debridement alone versus debridement combined with topical antifungal nail lacquer for the treatment of pedal onychomycosis: A randomized, controlled trial. J Foot Ankle Surg 2009;48:294-308.
58. Grover C, Bansal S, Nanda S, Reddy BS, Kumar V. Combination of surgical avulsion and topical therapy for single nail onychomycosis: A randomized controlled trial. Br J Dermatol 2007;157:364-8. (Pubitemid 47083855)
59. Gianni C, Romano C. Clinical and histological aspects of toenail onychomycosis caused by Aspergillus spp.: 34 cases treated with weekly intermittent terbinafine. Dermatology 2004;209:104-10. (Pubitemid 39179079)
60. Tosti A, Piraccini BM, Lorenzi S, Iorizzo M. Treatment of nondermatophyte mold and Candida onychomycosis. Dermatol Clin 2003;21:491-7. (Pubitemid 37022672)
61. Cribier BJ, Bakshi R. Terbinafine in the treatment of onychomycosis: A review of its efficacy in high-risk populations and in patients with nondermatophyte infections. Br J Dermatol 2004;150:414-20. (Pubitemid 38446294)
62. Rigopoulos D, Katoulis AC, Ioannides D, Georgala S, Kalogeromitros D, Bolbasis I, et al. A randomised trial of amorolfine 5 % nail solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis. Br J Dermatol 2003;149:151-6. (Pubitemid 36966525)
63. Scher RK, Baran R. Onychomycosis in clinical practice: Factors contributing to recurrence. Br J Dermatol 2003;149 Suppl 65:5-9. (Pubitemid 37410064)
64. Ratajczak-Stefa?ska V. Assessment of mycological and clinical factors on the course and results of treatment of mycotic infections in patients with recurrent onychomycosis. Ann Acad Med Stetin 2003;49:161-71.
65. Sigurgeirsson B. Prognostic factors for cure following treatment of onychomycosis. J Eur Acad Dermatol Venereol 2010;24:679-84.
66. Gupta AK, Ryder JE. How to improve cure rates for the management of onychomycosis. Dermatol Clin 2003;21:499-505. (Pubitemid 37022673)
67. Thappa DM. Current treatment of onychomycosis. Indian J Dermatol Venereol Leprol 2007;73:373-6.
68. Ginter-Hanselmayer G, Weger W, Smolle J. Onychomycosis: A new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients. J Eur Acad Dermatol Venereol 2008;22:470-5. (Pubitemid 351436919)
69. Gupta AK, Chang P, Del Rosso JQ, Adam P, Hofstader SL. Onychomycosis in children: Prevalence and management. Pediatr Dermatol 1998;15:464-71. (Pubitemid 29006184)
70. Gupta AK, Konnikov N, Lynde CW. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly. J Am Acad Dermatol 2001;44:479-84. (Pubitemid 32199968)
71. Dogra S, Kumar B, Bhansali A, Chakrabarty A. Epidemiology of onychomycosis in patients with diabetes mellitus in India. Int J Dermatol 2002;41:647-51. (Pubitemid 35252039)
72. Sumikawa M, Egawa T, Honda I, Yamamoto Y, Sumikawa Y, Kubota M. Effects of foot care intervention including nail drilling combined with topical antifungal application in diabetic patients with onychomycosis. J Dermatol 2007;34:456-64. (Pubitemid 46957477)
73. Mayser P, Freund V, Budihardja D. Toenail onychomycosis in diabetic patients: Issues and management. Am J Clin Dermatol 2009;10:211-20.